JP2019142974A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019142974A5 JP2019142974A5 JP2019096298A JP2019096298A JP2019142974A5 JP 2019142974 A5 JP2019142974 A5 JP 2019142974A5 JP 2019096298 A JP2019096298 A JP 2019096298A JP 2019096298 A JP2019096298 A JP 2019096298A JP 2019142974 A5 JP2019142974 A5 JP 2019142974A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- aqueous solution
- combination
- water
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007864 aqueous solution Substances 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 12
- 229920003169 water-soluble polymer Polymers 0.000 claims 12
- 229920000642 polymer Polymers 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 10
- XYLJNLCSTIOKRM-UHFFFAOYSA-N Alphagan Chemical compound C1=CC2=NC=CN=C2C(Br)=C1NC1=NCCN1 XYLJNLCSTIOKRM-UHFFFAOYSA-N 0.000 claims 9
- 229960003679 brimonidine Drugs 0.000 claims 9
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims 8
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 229920005615 natural polymer Polymers 0.000 claims 6
- 229920002554 vinyl polymer Polymers 0.000 claims 6
- 239000003112 inhibitor Substances 0.000 claims 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims 3
- 229920002125 Sokalan® Polymers 0.000 claims 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 3
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 claims 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 3
- 239000007788 liquid Substances 0.000 claims 3
- 229920000609 methyl cellulose Polymers 0.000 claims 3
- 239000001923 methylcellulose Substances 0.000 claims 3
- 235000010981 methylcellulose Nutrition 0.000 claims 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims 3
- 239000000230 xanthan gum Substances 0.000 claims 3
- 229920001285 xanthan gum Polymers 0.000 claims 3
- 235000010493 xanthan gum Nutrition 0.000 claims 3
- 229940082509 xanthan gum Drugs 0.000 claims 3
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229920003174 cellulose-based polymer Polymers 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229960003260 chlorhexidine Drugs 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017235962 | 2017-12-08 | ||
| JP2017235962 | 2017-12-08 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018229557A Division JP6603785B2 (ja) | 2017-12-08 | 2018-12-07 | 水溶性高分子を含む水性液剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019142974A JP2019142974A (ja) | 2019-08-29 |
| JP2019142974A5 true JP2019142974A5 (enExample) | 2019-12-26 |
| JP6701412B2 JP6701412B2 (ja) | 2020-05-27 |
Family
ID=66751450
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018229557A Active JP6603785B2 (ja) | 2017-12-08 | 2018-12-07 | 水溶性高分子を含む水性液剤 |
| JP2019096298A Active JP6701412B2 (ja) | 2017-12-08 | 2019-05-22 | 水溶性高分子を含む水性液剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018229557A Active JP6603785B2 (ja) | 2017-12-08 | 2018-12-07 | 水溶性高分子を含む水性液剤 |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JP6603785B2 (enExample) |
| WO (1) | WO2019112030A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6628924B2 (ja) * | 2018-06-05 | 2020-01-15 | 千寿製薬株式会社 | 水性液剤 |
| JP2020033290A (ja) * | 2018-08-29 | 2020-03-05 | 興和株式会社 | 水性組成物 |
| TWI833913B (zh) * | 2019-02-27 | 2024-03-01 | 日商參天製藥股份有限公司 | 含有迪夸弗索(diquafosol)或其鹽、乙烯系高分子及纖維素系高分子之眼科用組合物 |
| JP6797992B1 (ja) * | 2019-09-30 | 2020-12-09 | 千寿製薬株式会社 | 水性液剤 |
| JP6798001B1 (ja) * | 2019-12-27 | 2020-12-09 | 千寿製薬株式会社 | 医薬製品 |
| CN117571883B (zh) * | 2024-01-15 | 2024-03-19 | 四川智强医药科技开发有限公司 | 一种酒石酸溴莫尼定滴眼液的质量检测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3499882B2 (ja) * | 1992-03-09 | 2004-02-23 | 日本製薬株式会社 | 粘性すり込み用消毒剤 |
| JPH07267840A (ja) * | 1994-03-30 | 1995-10-17 | Sunstar Inc | 口腔用組成物 |
| JPH10203960A (ja) * | 1997-01-24 | 1998-08-04 | Ofutekusu:Kk | 点眼液組成物 |
| JP2011042682A (ja) * | 1997-05-20 | 2011-03-03 | Senju Pharmaceut Co Ltd | 水性製剤の増粘剤 |
| WO2004073708A1 (en) * | 1998-12-17 | 2004-09-02 | Dean Thomas R | Brinzolamide and brimonidine for treating ocular conditions |
| US20050026924A1 (en) * | 2000-07-14 | 2005-02-03 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
| AU2003216213B2 (en) * | 2002-02-07 | 2008-10-02 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides |
| US9089562B2 (en) * | 2013-08-28 | 2015-07-28 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| SG10201901426WA (en) * | 2015-03-06 | 2019-03-28 | Santen Pharmaceutical Co Ltd | Ophthalmic composition |
| CN107427460A (zh) * | 2015-03-19 | 2017-12-01 | 阿勒根公司 | 溴莫尼定和噻吗洛尔的固定剂量组合 |
| HK1244689A1 (zh) * | 2015-05-28 | 2018-08-17 | 乐敦制药株式会社 | 水性眼科组合物 |
| TWI711453B (zh) * | 2015-06-05 | 2020-12-01 | 日商參天製藥股份有限公司 | 抑制水性點眼液中之洛赫西定類的殘存率降低之方法 |
| TW201733577A (zh) * | 2016-03-14 | 2017-10-01 | Santen Pharmaceutical Co Ltd | 含有多佐胺、噻嗎洛爾和界面活性劑之醫藥組成物 |
-
2018
- 2018-12-07 JP JP2018229557A patent/JP6603785B2/ja active Active
- 2018-12-07 WO PCT/JP2018/045044 patent/WO2019112030A1/ja not_active Ceased
-
2019
- 2019-05-22 JP JP2019096298A patent/JP6701412B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019142974A5 (enExample) | ||
| JP2019104727A5 (enExample) | ||
| US20110245202A1 (en) | Pharmaceutical composition for the treatment of rhinitis | |
| JP6683622B2 (ja) | 眼科用水性組成物 | |
| JP7524272B2 (ja) | 水溶性高分子を含む点眼剤 | |
| JP6701412B2 (ja) | 水溶性高分子を含む水性液剤 | |
| JP2019142979A5 (enExample) | ||
| RU2018112239A (ru) | Фармацевтическая композиция на основе трамадола для офтальмологического применения | |
| CN106714806B (zh) | 水性组合物 | |
| CN110785162B (zh) | 用于治疗青光眼的滴眼液组合物 | |
| US20130142837A1 (en) | Cellulosic gel composition with improved viscosity stability | |
| RU2016148820A (ru) | Стабилизированный раствор на основе активных веществ, способ получения стабилизированного раствора активных веществ, фармацевтическая композиция на основе стабилизированного раствора активных веществ (варианты) | |
| JP2014015450A (ja) | 水性眼科組成物 | |
| BR112013018025A2 (pt) | composição de bromfenac líquida aquosa método para reforçar a eficácia conservante de uma solução aquosa | |
| JP2011105706A (ja) | 眼科用剤 | |
| JP2017509668A (ja) | 高浸透圧ヒアルロン酸組成物 | |
| TWI712429B (zh) | 水性醫藥組成物 | |
| CN107668062A (zh) | 基于透明质酸的奥兰西丁水溶液及其制备方法和应用 | |
| RU2012103982A (ru) | Офтальмологические композиции с этиленоксид-бутиленоксидными блок-сополимерами | |
| EP2968277A1 (en) | Alpha-2 adrenergic agonist for treating intraocular pressure and ocular diseases through intravitreal and intracameral routes | |
| JP2018111691A (ja) | 眼科用水性組成物、及び化合物の含量低下を抑制する方法 | |
| JP5478680B2 (ja) | 水溶性高分子増粘剤を含有する組成物の安定化剤 | |
| JP7066909B1 (ja) | 高分子化合物、銀塩およびイオン性等張化剤を含有する水性点眼液 | |
| RU2025117766A (ru) | Фармацевтические композиции, содержащие апраклонидин, для снятия покраснения глаза | |
| JP5268231B2 (ja) | 水溶性高分子増粘剤を含有する組成物の安定化剤 |